8/20/24 14:23 | 8/16/24 | ABIO | Financ | InvAdv | Investment Advice | Janus Henderson Group Plc | X0 | T | | P | 17 | 2.93 | 0 | 6 | 0 | 2,117 | I | | | | | | | | | | | | | | |
7/26/24 10:50 | 7/24/24 | ABIO | Financ | InvAdv | Investment Advice | Janus Henderson Group Plc | X0 | T | | P.m | 699 | 3.18 | 0 | 220 | 12 | 2,111 | I | | | | | | | | | | | | | | |
7/12/24 19:38 | 7/3/24 | ABIO | Financ | InvAdv | Investment Advice | Janus Henderson Group Plc | X0 | T | | P.m | 1,427 | 3.49 | 0 | 409 | 28 | 1,891 | I | | | | | | | | | | | | | | |
5/25/22 17:12 | 5/23/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.dm | 197 | 2.32 | 0 | 85 | 3 | 2,580 | D | | | | | | | | | | | | | | |
5/20/22 18:01 | 5/18/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.dm | 30 | 2.30 | 0 | 13 | 1 | 2,495 | D | | | | | | | | | | | | | | |
5/16/22 19:31 | 5/12/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.dm | 194 | 2.29 | 0 | 85 | 4 | 2,482 | D | | | | | | | | | | | | | | |
5/11/22 18:38 | 5/10/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.dm | 104 | 2.28 | 0 | 46 | 2 | 2,397 | D | | | | | | | | | | | | | | |
5/9/22 17:44 | 5/5/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.dm | 283 | 2.28 | 0 | 124 | 6 | 2,352 | D | | | | | | | | | | | | | | |
5/2/22 19:03 | 4/28/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.dm | 78 | 2.31 | 0 | 34 | 2 | 2,228 | D | | | | | | | | | | | | | | |
4/27/22 18:33 | 4/25/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.d | 32 | 2.29 | 0 | 14 | 1 | 2,194 | D | | | | | | | | | | | | | | |
4/20/22 19:43 | 4/18/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.d | 21 | 2.31 | 0 | 9 | 0 | 2,180 | D | | | | | | | | | | | | | | |
4/14/22 20:04 | 4/14/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P | 41 | 2.33 | 0 | 17 | 1 | 2,171 | D | | | | | | | | | | | | | | |
4/12/22 19:31 | 4/8/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.m | 243 | 2.32 | 0 | 105 | 5 | 2,154 | D | | | | | | | | | | | | | | |
4/7/22 20:38 | 4/5/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.m | 240 | 2.31 | 0 | 104 | 5 | 2,049 | D | | | | | | | | | | | | | | |
4/7/22 20:36 | 4/4/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.a | 276 | 2.26 | 0 | 122 | 7 | 1,945 | D | | | | | | | | | | | | | | |
4/4/22 20:26 | 4/4/22 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P | 276 | 2.26 | 0 | 122 | 7 | 1,945 | D | | | | | | | | | | | | | | |
11/23/21 16:53 | 11/22/21 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Ozeroff Christopher David | CO | O | S.VP,GC | P | 113 | 2.26 | 0 | 50 | 999% | 51 | D | | | | | | | | | | | | | | |
5/13/21 17:00 | 5/12/21 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Conway Robert E | CO | DH | Chairman | P | 32 | 3.19 | 0 | 10 | 25 | 50 | D | | | | | | | | | | | | | | |
5/6/21 16:30 | 5/5/21 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Conway Robert E | CO | DH | Chairman | P | 32 | 3.23 | 0 | 10 | 33 | 40 | D | | | | | | | | | | | | | | |
12/21/20 16:15 | 12/18/20 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Conway Robert E | CO | DH | Chairman | P | 42 | 4.16 | 0 | 10 | 50 | 30 | D | | | | | | | | | | | | | | |
9/25/20 16:20 | 9/25/20 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Conway Robert E | CO | DH | Chairman | P | 21 | 4.28 | 0 | 5 | 33 | 20 | D | | | | | | | | | | | | | | |
9/24/20 16:20 | 9/22/20 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Conway Robert E | CO | DH | Chairman | P | 14 | 4.66 | 0 | 3 | 26 | 15 | D | | | | | | | | | | | | | | |
9/21/20 17:00 | 9/21/20 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Conway Robert E | CO | DH | Chairman | P | 48 | 4.77 | 0 | 10 | 514 | 12 | D | | | | | | | | | | | | | | |
7/17/17 16:08 | 7/14/17 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Conway Robert E | CO | DH | Chairman | P | 25 | 2.49 | 0 | 10 | 40 | 35 | D | | | | | | | | | | | | | | |
5/3/17 16:08 | 5/2/17 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Mitchell Daniel J | CO | D | | P | 30 | 2.71 | 0 | 11 | New | 11 | D | -57 | -40 | 14 | -6 | 0 | 6 | -4 | -7 | -3 | -6 | | | | |
3/27/17 16:06 | 3/24/17 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Conway Robert E | CO | D | | P | 65 | 2.59 | 0 | 25 | New | 25 | D | -51 | -27 | -10 | 2 | 4 | 4 | 6 | 6 | -1 | -1 | -3 | | | |
2/4/14 11:24 | 2/4/14 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | McCormack Riley | FL | T | | P.d | 1,700 | 1.70 | 1 | 1,000 | 50 | 3,000 | I | -68 | -52 | 34 | 38 | 24 | -7 | -14 | -5 | -2 | -6 | 0 | -17 | -24 | -63 |
1/28/13 17:04 | 1/25/13 | ABIO | Health | Diagn | In Vitro & In Vivo Diagnostic | Bristow Michael R | CO | DOT | P,CEO | P.d | 500 | 0.4676 | 0 | 1,069 | 96 | 2,184 | I | -88 | -62 | -27 | 27 | -16 | -5 | 3 | -3 | 2 | 68 | 34 | 3 | -41 | -18 |
3/25/08 12:56 | 3/24/08 | NUVO | Health | Diagn | In Vitro & In Vivo Diagnostic | Love Ted W | CA | DO | C.E.O | P | 19 | 0.6717 | 0 | 29 | 103 | 57 | D | | | | | | | | | | | | | | |
5/12/05 19:54 | 5/12/05 | NUVO | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Michael D | CA | O | SVP Rese | P | 57 | 6.31 | 0 | 9 | New | 9 | D | | | | | | | | | | | | | | |
2/24/05 16:36 | 2/23/05 | NUVO | Health | Diagn | In Vitro & In Vivo Diagnostic | Titus Gary | CA | O | VP Finan | P | 11 | 7.51 | 0 | 2 | 396 | 2 | D | | | | | | | | | | | | | | |
2/23/04 19:51 | 2/20/04 | NUVO | Health | Diagn | In Vitro & In Vivo Diagnostic | Zubrow Barry L | CA | D | | P | 233 | 4.65 | 0 | 50 | New | 50 | I | | | | | | | | | | | | | | |